These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 24484849)

  • 1. Contamination of hypertonic saline solutions in use by cystic fibrosis patients in Israel.
    Peled O; Kalamaro V; Kerem E; Shoseyov D; Blau H; Efrati O; Block C
    J Cyst Fibros; 2014 Sep; 13(5):550-6. PubMed ID: 24484849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Tolerance of two inhaled hypertonic saline solutions in patients with cystic fibrosis].
    Máiz Carro L; Lamas Ferreiro A; Ruiz de Valbuena Maiz M; Wagner Struwing C; Gabilondo Álvarez G; Suárez Cortina L
    Med Clin (Barc); 2012 Feb; 138(2):57-9. PubMed ID: 21511313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term efficacy of ultrasonically nebulized hypertonic saline in cystic fibrosis.
    Eng PA; Morton J; Douglass JA; Riedler J; Wilson J; Robertson CF
    Pediatr Pulmonol; 1996 Feb; 21(2):77-83. PubMed ID: 8882210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertonic saline treatment of cystic fibrosis.
    Taylor LM; Kuhn RJ
    Ann Pharmacother; 2007 Mar; 41(3):481-4. PubMed ID: 17327291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of hypertonic saline, amiloride, and cough on mucociliary clearance in patients with cystic fibrosis.
    Robinson M; Regnis JA; Bailey DL; King M; Bautovich GJ; Bye PT
    Am J Respir Crit Care Med; 1996 May; 153(5):1503-9. PubMed ID: 8630593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival dynamics of cystic fibrosis-related Gram-negative bacterial pathogens (Pseudomonas aeruginosa and Burkholderia cenocepacia) in Dead Sea and Atlantic Ocean waters.
    Shteinberg M; Kis-Papo T; Millar BC; Rendall JC; Downey DG; Elborn JS; Moore JE
    J Water Health; 2015 Sep; 13(3):773-6. PubMed ID: 26322762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rheology of cystic fibrosis sputum after in vitro treatment with hypertonic saline alone and in combination with recombinant human deoxyribonuclease I.
    King M; Dasgupta B; Tomkiewicz RP; Brown NE
    Am J Respir Crit Care Med; 1997 Jul; 156(1):173-7. PubMed ID: 9230743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pilot study of safety and tolerability of inhaled hypertonic saline in infants with cystic fibrosis.
    Subbarao P; Balkovec S; Solomon M; Ratjen F
    Pediatr Pulmonol; 2007 May; 42(5):471-6. PubMed ID: 17436328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertonic saline improves the LCI in paediatric patients with CF with normal lung function.
    Amin R; Subbarao P; Jabar A; Balkovec S; Jensen R; Kerrigan S; Gustafsson P; Ratjen F
    Thorax; 2010 May; 65(5):379-83. PubMed ID: 20435858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and tolerability of inhaled hypertonic saline in young children with cystic fibrosis.
    Dellon EP; Donaldson SH; Johnson R; Davis SD
    Pediatr Pulmonol; 2008 Nov; 43(11):1100-1106. PubMed ID: 18828160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhaled hypertonic saline in infants and toddlers with cystic fibrosis: short-term tolerability, adherence, and safety.
    Rosenfeld M; Davis S; Brumback L; Daniel S; Rowbotham R; Johnson R; McNamara S; Jensen R; Barlow C; Ratjen F
    Pediatr Pulmonol; 2011 Jul; 46(7):666-71. PubMed ID: 21365779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbial contamination of non-invasive ventilation devices used by adults with cystic fibrosis.
    Mutagi A; Nash EF; Cameron S; Abbott G; Agostini P; Whitehouse JL; Honeybourne D; Boxall E
    J Hosp Infect; 2012 Jun; 81(2):104-8. PubMed ID: 22579442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A day in the life of a nebulizer: surveillance for bacterial growth in nebulizer equipment of children with cystic fibrosis in the hospital setting.
    O'Malley CA; VandenBranden SL; Zheng XT; Polito AM; McColley SA
    Respir Care; 2007 Mar; 52(3):258-62. PubMed ID: 17328823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rationale for hypertonic saline therapy for cystic fibrosis lung disease.
    Tarran R; Donaldson S; Boucher RC
    Semin Respir Crit Care Med; 2007 Jun; 28(3):295-302. PubMed ID: 17562499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypertonic saline for cystic fibrosis: worth its salt?
    Goralski JL; Donaldson SH
    Expert Rev Respir Med; 2014 Jun; 8(3):267-9. PubMed ID: 24666113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-use Hypertonic Saline Packets for Nebulization - A Threat for Patients with Cystic Fibrosis in India.
    Varkki S; Rose W
    Indian Pediatr; 2019 Dec; 56(12):1068-1069. PubMed ID: 31884452
    [No Abstract]   [Full Text] [Related]  

  • 17. Microbial contamination of nebulizers in the home treatment of cystic fibrosis.
    Blau H; Mussaffi H; Mei Zahav M; Prais D; Livne M; Czitron BM; Cohen HA
    Child Care Health Dev; 2007 Jul; 33(4):491-5. PubMed ID: 17584406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical value of obtaining sputum and cough swab samples following inhaled hypertonic saline in children with cystic fibrosis.
    Ho SA; Ball R; Morrison LJ; Brownlee KG; Conway SP
    Pediatr Pulmonol; 2004 Jul; 38(1):82-7. PubMed ID: 15170878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting response to rhDNase and hypertonic saline in children with cystic fibrosis.
    Suri R; Metcalfe C; Wallis C; Bush A
    Pediatr Pulmonol; 2004 Apr; 37(4):305-10. PubMed ID: 15022126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pseudomonas aeruginosa and Burkholderia cenocepacia infections in patients affected by cystic fibrosis: serum resistance and antibody response.
    Savoia D; Deplano C; Zucca M
    Immunol Invest; 2008; 37(1):19-27. PubMed ID: 18214797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.